Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma
Christina Pamporaki(University Hospital Carl Gustav Carus), Graeme Eisenhofer(University Hospital Carl Gustav Carus), Jacques W.M. Lenders(Radboud University Nijmegen), David Taïeb(Aix-Marseille Université), Felix Beuschlein(University of Zurich), Tamara Prodanov(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Annika M.A. Berends(University Medical Center Groningen), Andrzej Januszewicz(Hypertension Institute), Henri Timmers(Radboud University Nijmegen), Nicole Bechmann(University Hospital Carl Gustav Carus), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Karel Pacák(Endocrine Society), Georgiana Constantinescu(Technische Universität Dresden), Leah Meuter(Stanford Medicine), Michiel N. Kerstens(University Medical Center Groningen), Hanna Remde(University of Würzburg)
Cited by 43
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665